![Deborah Baron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Deborah Baron
Direttore/Membro del Consiglio presso
CEREVEL THERAPEUTICS HOLDINGS, INC.
Profilo
Deborah Baron is currently Chief Executive Officer at Amplyx Pharmaceuticals, Inc., Director at Seagen, Inc. since 2023, Independent Director at Cerevel Therapeutics Holdings, Inc. since 2021, Director at Cerevel Therapeutics, Inc., Director at Metsera, Inc. starting in 2025, and President at Encysive Pharmaceuticals, Inc. Former roles include Director at Global Blood Therapeutics, Inc., President & Director at Trillium Therapeutics, Inc., and Senior VP-Worldwide Business Development at Pfizer Inc. Education includes undergraduate studies at Massachusetts Institute of Technology and an MBA from MIT Sloan School of Management.
Posizioni attive di Deborah Baron
| Società | Posizione | Inizio |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Direttore/Membro del Consiglio | 20/01/2021 |
| SEAGEN INC. | Direttore/Membro del Consiglio | 14/12/2023 |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Amministratore Delegato | - |
Cerevel Therapeutics, Inc.
 Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Direttore/Membro del Consiglio | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Presidente | - |
Precedenti posizioni note di Deborah Baron
| Società | Posizione | Fine |
|---|---|---|
| TRILLIUM THERAPEUTICS | Presidente | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Direttore/Membro del Consiglio | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Formazione di Deborah Baron
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
13
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Amplyx Pharmaceuticals, Inc.
Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes medicines | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapies | Health Technology |
